The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How RFI/RFP Optimization Changes The Game
Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
-
How Can Electronic Data Capture Better Serve Decentralized Clinical Trials?
Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?
-
A Guide To Medical Coding In Clinical Trials
Medical coding transforms free-text clinical data into standardized terminology, enabling consistent analysis, safety monitoring, and regulatory review. Clear guidelines and quality control help reduce variability and protect data integrity across the entire clinical trial lifecycle.
-
The ROI Of eRegulatory And eIRB Integration
This article outlines common eReg management system integrations, and highlights a new integration already allowing sites to save hundreds or thousands of dollars per protocol.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
This case study showcases how advanced analytics were used to streamline feasibility planning for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
How Site eSource Completes And Extends The EHR To EDC Initiative
This study evaluates to what degree an eSource-to-EDC data transfer initiative succeeds through two key dimensions: "Mappability" and "Prevalence".
-
Navigating The Next Wave Of Innovation In eCOA
Learn how the right eCOA system enables site efficiency and elevated data quality, ensuring trials run smoothly and deliver more reliable results.
-
No More Back And Forth: Building eCOAs Right The First Time
Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.
-
Evidence Generation Evolved
Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
What Is eCOA?
Learn how electronic tools replace paper processes, support decentralized trials, and help research teams collect more reliable clinical data.
RECENT NEWSLETTERS
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials